VXRT
Vaxart Inc
Halal Rating :
Last Price
$0.76
Last updated:
Market Cap
-
7D Change
5.53%
1 Year Change
-1.3%
Company Overview
Industries
Exchange
Next Earnings Date
Vaxart, Inc. is a clinical-stage biotechnology company focused on developing oral recombinant vaccines based on its proprietary VAAST platform. The company aims to develop oral tablet vaccines for various infectious diseases, including COVID-19, norovirus, and seasonal influenza. Their innovative approach involves creating vaccines that can be administered orally rather than through traditional injection methods.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $4.93m | $20.04m | - | $631000.0 | 0.00% | 3.15% |
| June 30, 2024 | $6.4m | $23.27m | - | $610000.0 | 0.00% | 2.62% |
| March 31, 2024 | $2.18m | $27.05m | - | $804000.0 | 0.00% | 2.97% |
Company Impact
Help us evaluate Vaxart Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.